Interest in psychedelic medicine for traumatic brain injury has accelerated rapidly in recent years, with ibogaine and psilocybin emerging as two of the most promising compounds under investigation.

A fascinating new case series has added to the growing conversation around psychedelics and brain injury recovery.

Emerging evidence in individuals with traumatic brain injury suggests psychedelics may drive meaningful improvements in cognition, mood, and trauma, signalling a potential paradigm shift in neurorehabilitation.

I’ve conducted an independently led study exploring the effects of psychedelics on individuals living with brain injury.